Related Experiment Videos

Renal failure due to cholesterol embolization following percutaneous transluminal renal angioplasty

T Koga1, S Okuda, S Takishita

  • 1Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Insights

Cholesterol embolization syndrome can occur after renal angioplasty, leading to kidney failure. Careful patient selection is crucial for renovascular hypertension treatment.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pathology

Background:

  • Renovascular hypertension poses significant risks, especially in patients with compromised renal function.
  • Diffuse atherosclerosis and diabetes mellitus are common comorbidities that increase procedural risks.
  • Solitary functioning kidney necessitates meticulous management to preserve renal function.

Observation:

  • A 63-year-old diabetic woman with renovascular hypertension and a solitary functioning kidney underwent successful renal angioplasty.
  • Post-procedure, the patient developed fever, myalgia, and progressive elevations in blood urea nitrogen and creatinine.
  • Within a month, the patient became uremic, requiring dialysis, and passed away six months later.

Findings:

  • Autopsy confirmed cholesterol crystal embolization in the kidneys, pancreas, and spleen.
  • Cholesterol embolization syndrome was identified as the cause of subacute renal failure.
  • The findings highlight a rare but severe complication of percutaneous transluminal renal angioplasty.

Implications:

  • This case underscores the critical need for thorough patient assessment before renal angioplasty in high-risk individuals.
  • Minimizing procedural trauma and considering alternative treatments may be warranted for patients with solitary kidneys.
  • Enhanced vigilance for cholesterol embolization syndrome post-procedure is essential for early diagnosis and management.

Related Concept Videos